Replies to post #76831 on Biotech Values

[jbog]

Rkrw

For more than two years, the stock has been extremely volatile, in part because of its large short interest as investors placed bets on the success of Provenge.

The most recent data shows 21.6 million shares, or 22.3% of shares outstanding, were bet against the stock as of April 15, up from 19.4 million shares, or 20% of shares, just two weeks earlier.

[jbog]

DNDN is now trading at $27ish